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Prevalence of Metabolic Syndrome among Hypertensive Patients in 
Hadhramout, Republic of Yemen 
 




The aim of this study was to determine the prevalence of metabolic syndrome among hypertensive patients. A cross-
sectional study conducted at Al-Rayan Specialized Hospital, Mukalla, Hadramout during (2/2015 - 4/2016). From 
345 patients, 207 were diagnosed as metabolic syndrome (60%), with mean age (57.9±9.2) years was significantly 
higher than that of patients without the syndrome (44.7±6.6) years (p ˂0.0001). Females with the syndrome were 
significantly higher than males (67.6% and 32.4% respectively) compared with patients without, (p ˂0.0001). As 
Hypertension was present in all studied patients, diabetes was the commonest metabolic syndrome component in 
patients with the syndrome (79.2%), followed by the high waist circumference (76.3%), then high triglycerides 
(66.2%) and the least was low HDL (59.9%). There was 58% of patients with metabolic syndrome had four metabolic 
syndrome components, 32.8% with five and only 7.2% had only three components. The prevalence of metabolic 
syndrome among hypertensive patients was high. It was more common in females and older age. Diabetes and the 
central obesity were the most frequent syndrome components. More than half of patients had four components, but a 
considerable number of patients were with the all the five components.  
 
Keywords: Metabolic Syndrome, Hypertension, Diabetes, Hadramout, Yemen. 
 
Introduction: 
Hypertension (HTN) and Metabolic syndrome 
(MetS) are highly prevalent diseases that present 
a global challenge [9,16]. In 2000, approximately 
1 billion people worldwide (26.4% of the adult 
population) were estimated to have HTN and this 
is likely to increase to over 1.5 billion by 2025 as 
a result of aging population in many developed 
countries, and an increasing incidence of HTN in 
developing countries [16]. It is estimated that 
around 20-25% of the world’s adult population 
has MetS and they are twice as likely to die from 
it; and they are three times more likely to have a 
heart attack or stroke compared with people 
without the syndrome [33]. When HTN and 
MetS components co-exist in an individual they 
potentiate one another leading to synergism that 
increase the total risk [24]. Hypertension is one 
of the major manifestations of the group of 
clinical abnormalities that characterize MetS 
[19]. Use of some antihypertensive agents like 
diuretics or β-adrenergic blocking agents may 
worsen insulin resistance and increase the risk of 
developing cardiovascular disease [15].  
Even though there are different studies done on 
the prevalence of MetS in different parts of the 
world [14,15,25,35], in neighbour countries 
[2,3,6,26]; and few reports on MetS in the area 
were specifically performed among hypertensive 
individuals [29]. In Republic of Yemen, only 
three published studies were performed on MetS 
[1,4,7], in the fourth study was our work in 
Hadramout [5]. Hence, the aim of this study was 
to determine the prevalence of MetS among 
hypertensive patients in Hadramout. 
 
Subjects and Methods: 
This prospective cross-sectional hospital-based 
study was carried out at the medical department 
and outpatient clinic of Al-Rayan specialized 
Hospital, Mukalla, Hadramout, Republic of 
Yemen, during the period from February 2015 to 
April 2016. Previously hypertensive patients 
were submitted to the study after exclusion 
criteria had been applied, which were: Type 1 
diabetes mellitus (DM), secondary DM or HTN, 
any evidence of non-diabetic or non-
hypertensive renal disease, or severe renal 
disease, severe heart failure (New York Heart 
Association class III or more), liver disease, and 
pregnancy.  
Ethically, a written consent from most patients or 
his/her guardian was taken as an agreement to 
participate in the study, few patients were illiterate 
or old and verbal agreement was declared. 
All patients underwent detailed History taking 
and clinical examination, including 
measurements of weight, waist circumference 
(WC), and blood pressure. Fasting venous blood 
was sampled from an antecubital vein from all 
patients for the measurement of plasma glucose 
(FPG), high-density lipoprotein (HDL), 
triglycerides (TGs), urea and creatinine.  
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Metabolic syndrome was diagnosed, according to 
The National Cholesterol Education Program 
(NCEP), Adult Treatment Panel III (ATP-III), in 
patients fulfilling three or more of the following [11]:  
1- Abdominal obesity (waist circumference > 
102 cm in men and > 88 cm in women). 
2- TGs   >1.7 mmol/l (150 mg /dl),  
3- HDL <1.04 mmol/L [40 mg/dL] for men and 
<1.30 mmol/L [50 mg/dL] for women)  
4- High fasting plasma glucose (FPG) ≥6.1 
mmol/L [≥110 mg/dL] or taking anti-
hyperglycemic drugs). 
5- High blood pressure (systolic blood pressure 
≥130 mmHg or diastolic blood pressure ≥85 
mmHg or taking antihypertensive drugs. 
The sample size was estimated using the formula 
for descriptive study (n= Zα
2
 X p X q/ d
2
) [10], 
where n is the sample desirable, Zα is the 
confidence level at 95% (1.96), d is the desirable 
precision at 5% (0.05), p is the previous 
prevalence of MetS in hypertensive patients in 
Kuwait; (34%) [29], q is 1-p which is equal to 
0.66. Based on the above formula, the minimal 
sample size was 345. Then, systematic sampling  
 
was applied and every second a participant was 
selected using systematic random sampling 
technique.    
Data were processed by The Statistical Package 
for Social Sciences (SPSS) software version 20.0 
(IBM Corporation, Armonk, NY, USA). The 
paired "t" test was applied to compare means and 
Pearson's chi-square test to compare gender and 
MetS components. Also we estimated odds ratio 
(OR) and the resulting confidence interval (95% 
CI) for all categorical variables. All statistical 
hypothesis tests were 2-sided, and p values <0.05 
were considered statistically significant. Microsoft 
office Excel 2010 was used to form the figures. 
 
Results  
On the basis of ATPIII criteria [11], 60% (207 / 
345) patients fulfilled the criteria for MetS and 
138 (40%) without MetS (Figure1). The mean 
age of Mets patients was (57.9±9.2) years, and 
was highly significant comparing with patients 
without the syndrome (44.7±6.6) years. All 
means of the five components of MetS were 
significantly higher in MetS patients than those 








































Metabolic syndrome (N=345)  
P value Yes  (n=207) 
Mean ± SD 
No (n= 138 ) 
Mean ± SD 





 99.2±6.3 85.6±5 ˂ 0.0001 
SBP
3
 (mm.Hg) 145±11.1 142.1±14.1 0.037 
DBP
4
(mm.Hg) 89.8±5.9 88.3±6.8 0.035 
TGs
5
 (mg/dl) 154.1±13.3 124.8±11.9 ˂ 0.0001 
HDL
6
 (mg/dl) 41.8±8.7 49±4.8 ˂ 0.0001 
FPG
7
 (mg/dl) 132.2±15.1 97.2±5.1. ˂ 0.0001 
1Waist Circumference 2centimeters   3Systolic Blood Pressure  4Diastolic Blood Pressure  5Triglycerides 6High-Density 
Lipoprotein  7Fasting Plasma Glucose   
 
Females (140, 67.5%) were significantly higher 
than males with MetS (67, 32.4%), [OR 0.28, 
95% CI (0.18-0.44), p ˂ 0.0001]. After HTN, 
DM was the most common MetS component in 
MetS patients (164, 79.2%), followed by high 
WC (158, 76.3%), high TGs (137, 66.2%), and 
low HDL (124, 59.9%) was the least frequent 
MetS component. All these components were 
higher in frequency among MetS patients 
comparing non-MetS patients with statistical 
significance, and they had stronger association 
with MetS than non-MetS patients with logistic 
regression; diabetes [OR 2.24(1.38-3.62)95% CI 
(1.38-3.62), p = 0.0009], high WC [OR 2.01, 
95% CI (1.23-3.27), p ˂ 0.0001], raised TGs [OR 
4.04, 95% CI (2.56-6.39), p ˂ 0.0001], and low 
HDL [OR 6.75, 95% CI (4.04-11.3), p ˂ 0.0001] 
(Table 2). 
 
Table 2 Frequency of Gender and Components of Metabolic Syndrome 
 




 P  value 







0.28 (0.18-0.44) ˂ 0.0001 
High WC
3
 158 (76.3%) 39 (44.3%) 2.01(1.23-3.27) ˂ 0.0001 
Diabetes 164(79.2%) 87(63%) 2.24(1.38-3.62) 0.0009 
Raised TGs
4
 137(66.2%) 45(32.6%) 4.04(2.56-6.39) ˂ 0.0001 
Low HDL
5
 124(59.9%) 25(18.1%) 6.75(4.04-11.3) ˂ 0.0001 
1Odds Ratio. 295% Confidence Interval. 3Waist circumference. 4Triglycerides.  5High-density lipoprotein. 
 
Regarding the distribution of MetS patients, 120 (58%) had 4 Components (criteria) of MteS, 72 (34.8%) 
had 5 components, and only 15 (7.2%) were with 3 components. (Figure2). 
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No of Patients 
Figure 2 Distribution of Patients according to Number of Metabolic syndrome Components 
 
Discussion: 
This study showed a high prevalence of MetS 
among hypertensive patients attending follow-up 
at the medical clinic and department of Al-Rayan 
Specialized Hospital, using the NCEP-ATP 
criteria (60%). Although many studies world-
wide were in the range of 30-50% [17,18,21,23], 
higher figures were reported [12,30]. This 
variation was also recorded in the same region, 
in the Middle East, Yasin et al. [34] in Jordan 
reported about twice than Sorkhou et al. [29] in 
Kuwait (65% and 34% respectively). In India, 
Govindula et al. [12], Thakur et al. [32], and 
Salegre et al. [27], found that the prevalence of 
MetS were (82.5%, 68.6% and 49% 
respectively). The possible explanations for the 
variation could be genetic disparities between 
populations, ethnicity, socio-demographic 
characteristics, lifestyle, duration of HTN and 
experiences of antihypertensive treatment. 
Recently Tedewos et al, found that the 
prevalence of MetS in urban inhabitants was 
82.8% [31], therefore, it calls for a critical 
attention to create awareness for individuals 
living in urban situation concerning how to 
modify their life style in order to limit/prevent 
MetS risks. 
This study revealed that MteS patients were 
older than the non-MetS, with female 
predominance, and this was supported by many 
studies [20,28], the syndrome affecting less than 
10% of people in their 20s and 40% of people in 
their 60s [13] and recently Nolan et al, in a 
pooled analysis reported only 5-7% among 
young adult [22]. 
The frequency of each MetS component among 
hypertensive patient was variable, the most 
frequent MetS component among MetS patients 
in this work after HTN was DM, followed by 
high WC, high TGs and the least frequent was 
low HDL, Selagre et al, in India, [27] was very 
similar to our findings except that WC and TGs 
replaced their arrangements, but in many studies 
around the globe, WC was the most frequent, and 
DM was the least [8,32,34,35].  
More than 90% of our MetS patients had ˃3 
components (58% with 4 and 34.8% with all the 
5 components) while only 7.2% were with three 
components, while many studied showed that 
more patients were with three component, and 
the least were with 5 components (10.2-17%) 
[8,12,27,31], so, our people have a higher risk 
for coronary artery diseases and stroke, and 




The prevalence of metabolic syndrome among 
hypertensive patients was 60%. It was more 
common in females and older age. Diabetes is 
the most common component followed by high 
waist circumference (central obesity), high serum 
triglycerides and least frequent one was the 
serum low HDL Most patients had ˃3 
components of the syndrome.  
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 ستقالبية بني مرضى ارتفاع ضغط الدم الاملتالزمة ا
 اجلمهورية اليمنية -يف حضرموت
 




جريت في أفاع ضغط الدم. وىي دراسة مقطعية ستقالبية عند مرضى ارتالنتشار المتالزمة ااىو معرفة  ةكان اليدف من ىذه الدراس
منيم تم تشخيصيم كمرضى  207, اً مريض 345من م. 4/2016-2/2015مستشفى الريان التخصصي بالمكال حضرموت خالل الفترة 
حصائية عن متوسط أعمار المرضى بدون إبداللة عمى  أ( عام و ىو 9.2±  57.9عمارىم )أ%( ومتوسط 60الزمة االستقالبية )بالمت
% و 67.6بداللة من نسبة الذكور ) و  ىعمأناث المرضى بالمتالزمة  كانت إلنسبة ا (p ˂0.0001)( عام 6.6±  44.7المتالزمة )
يع المرضى, فإن داء السكري كون ارتفاع ضغط الدم لدى جم .(p ˂0.0001)% عمى الترتيب( مقارنة بالمرضى بدون المتالزمة 32.4
قميم ىو أ%( و 66.2رتفاع الدىون الثالثية )%(, ثم ا76.3محيط الخصر )%( يميو ارتفاع 79.2كثر نسبة بين مرضى المتالزمة )ألىو ا
ربعة من مكونات المتالزمة, و أ% من مرضى المتالزمة لدييم 58ان %(. و ك59.9نسبة انخفاض البروتين الدىني عالي الكثافة )
ستقالبية عند مرضى النتشار المتالزمة ااسبة % منيم فقط لدييم ثالثة مكونات من مكونات المتالزمة. ن7.2% لدييم خمسة, بينما 32.8
كثر أت المتالزمة. كثر شيوعا بين مكوناأللسن. داء السكري والسمنة كانا اكثر بين اإلناث و كبار اأضغط الدم كان مرتفعا. و ىو  ارتفاع
 الخمسة.مكونات بينما ىناك نسبة كبيرة منيم لدييم كافة مكونات المتالزمة  4من نصف المرضى كان لدييم 
 ستقالبية, ارتفاع ضغط الدم, السكري, حضرموت, اليمن.ال: المتالزمة االكممات المفتاحية
 
 
